Literature DB >> 23921818

Calcium-channel blockers and breast cancer: a hypothesis revived.

Patricia F Coogan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23921818     DOI： 10.1001/jamainternmed.2013.9069

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  4 in total

1.  Association Between Antihypertensive Medication Use and Breast Cancer: A Systematic Review and Meta-Analysis.

Authors:  Yuxiu Xie; Men Wang; Peng Xu; Yujiao Deng; Yi Zheng; Si Yang; Ying Wu; Zhen Zhai; Dai Zhang; Na Li; Nan Wang; Jing Cheng; Zhijun Dai
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

Review 2.  Hypertension and breast cancer risk: a systematic review and meta-analysis.

Authors:  Hedong Han; Wei Guo; Wentao Shi; Yamei Yu; Yunshuo Zhang; Xiaofei Ye; Jia He
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

3.  Altering bioelectricity on inhibition of human breast cancer cells.

Authors:  Seher Berzingi; Mackenzie Newman; Han-Gang Yu
Journal:  Cancer Cell Int       Date:  2016-09-22       Impact factor: 5.722

4.  Anticancer Effects of Antihypertensive L-Type Calcium Channel Blockers on Chemoresistant Lung Cancer Cells via Autophagy and Apoptosis.

Authors:  Gwo-Tarng Sheu; Ting-Tat Chan; Bing-Sang Wong; Ling-Yen Chiu; Dom-Gene Tu
Journal:  Cancer Manag Res       Date:  2020-03-13       Impact factor: 3.989
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.